FY25 Key Financial Results and Annual Report
Released
Latest announcements
Announcement summary
FY25 Key Financial Results and Annual Report
Starpharma (ASX: SPL, OTCQX: SPHRY), an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient, today releases its annual report and full-year financial results for the year ended 30 June 2025.
Ask a question
Your question will be sent privately to Starpharma. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Starpharma a question about this announcement.